Rene-Jean Bensadoun
Overview
Explore the profile of Rene-Jean Bensadoun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
2389
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Robijns J, Nair R, Lodewijckx J, Arany P, Barasch A, Bjordal J, et al.
Front Oncol
. 2022 Sep;
12:927685.
PMID: 36110957
Disclaimer: This article is based on recommendations from the 12 WALT Congress, Nice, October 3-6, 2018, and a follow-up review of the existing data and the clinical observations of an...
12.
Gobbo M, Merigo E, Arany P, Bensadoun R, Santos-Silva A, Gueiros L, et al.
Front Oral Health
. 2022 Jul;
3:945718.
PMID: 35874125
Background: Radiotherapy and chemotherapy are frequently employed in head and neck cancer (HNC) patients causing significant side effects that impair life quality and prognosis. Photobiomodulation (PBM) has become a growing...
13.
Klausner G, Troussier I, Canova C, Bensadoun R
Support Care Cancer
. 2021 Oct;
30(1):13-19.
PMID: 34623486
No abstract available.
14.
Bensadoun R, Bollet M, Liem X, Cao K, Magne N
Support Care Cancer
. 2021 Sep;
30(2):1569-1577.
PMID: 34537889
Purpose: The study aims to assess the feasibility, safety, and tolerability of CareMin650, a new photobiomodulation device, in patients treated by radiotherapy (RT) and to collect preliminary data on efficacy...
15.
Rodrigues-Oliveira L, Kowalski L, Santos M, Marta G, Bensadoun R, Martins M, et al.
Oral Oncol
. 2021 May;
118:105296.
PMID: 33933777
Mucositis is one of the more frequent and costly adverse events following cancer treatment. To evaluate and report the direct economic outcomes associated with the management of mucositis across several...
16.
Courtois E, Bouleftour W, Guy J, Louati S, Bensadoun R, Rodriguez-Lafrasse C, et al.
BMC Oral Health
. 2021 Apr;
21(1):220.
PMID: 33926421
Background: Oral mucositis (OM) is a severe complication cancer patients undergo when treated with chemoradiotherapy. Photobiomodulation (PBM) therapy also known as low-level laser therapy has been increasingly used for the...
17.
Nicolatou-Galitis O, Bossi P, Orlandi E, Bensadoun R
Support Care Cancer
. 2021 Mar;
29(10):5701-5709.
PMID: 33649918
Purpose: To discuss the role of benzydamine in the prevention and treatment of radiation-induced oral mucositis (OM) in head and neck (H&N) cancer patients. This document represents an expert opinion...
18.
Lacas B, Carmel A, Landais C, Wong S, Licitra L, Tobias J, et al.
Radiother Oncol
. 2021 Jan;
156:281-293.
PMID: 33515668
Background And Purpose: The Meta-Analysis of Chemotherapy in squamous cell Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) improved overall survival (OS) in patients without distant metastasis. We...
19.
Courtois E, Guy J, Axisa F, Saint-Girons P, Alston L, Houmera N, et al.
Lasers Med Sci
. 2020 Nov;
36(7):1445-1454.
PMID: 33169275
Photobiomodulation-based (PBM-based) therapies show promising results in mucositis and dermatitis treatment by stimulating wound healing mechanisms such as cell proliferation and migration. The aim of the present study is to...
20.
Bensadoun R, Epstein J, Nair R, Barasch A, Raber-Durlacher J, Migliorati C, et al.
Cancer Med
. 2020 Oct;
9(22):8279-8300.
PMID: 33107198
We performed a systematic review of the current literature addressing the safety and efficacy of photobiomodulation therapy (PBMT) in cancer patients. In this systematic review, the Preferred Reporting Items for...